ArticleJournal of hematology2025
Bilateral Avascular Necrosis of the Hips in a Patient With Sickle Cell Trait and Chronic Alcohol Use.
Article in Journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell trait (SCT) is generally considered a benign carrier state, unlike sickle cell disease (SCD), which is frequently associated with complications such as avascular necrosis (AVN). While AVN affects approximately 30% of patients with SCD, it is rarely reported in individuals with SCT and is not well understood. A 29-year-old African American male with SCT presented with progressively worsening hip pain. He reported chronic heavy alcohol use but denied steroid use, trauma or previous sickle cell crises. Physical exam demonstrated severely limited hip range of motion and antalgic gait. Laboratory studies were unremarkable aside from elevated C-reactive protein. Radiographs revealed bilateral femoral head AVN greater than stage II, with partial collapse on the left. He was managed conservatively with nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and counseling on alcohol reduction, and was referred to orthopedics for long-term management. Although rare, AVN can occur in individuals with SCT, particularly when compounded by modifiable risk factors such as chronic alcohol use, which can impair bone remodeling, promote fat embolism, and exacerbate microvascular compromise from intermittent sickling. It highlights the importance of early recognition and intervention in patients with unexplained joint pain, and that clinicians should maintain a high index of suspicion for AVN in SCT patients, especially in the presence of other comorbidities and risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.